A case of exacerbated encephalopathy with stroke-like episodes and lactic acidosis triggered by metformin in a patient with MELAS Hui Jin ShinJi-Hoon NaYoung-Mock Lee Brief Communication 24 January 2024 Pages: 2337 - 2339
Exploring thrombus composition in cerebral venous thrombosis: the first case report with initial insights and implications for treatment advancements Ghil SchwarzAngelo Cascio RizzoElio Clemente Agostoni Short Paper 15 January 2024 Pages: 2341 - 2345
A new perspective on positive symptoms: expression of damage or self-defence mechanism of the brain? Annibale AntonioniEmanuela Maria RahoGiacomo Koch Short Paper Open access 14 February 2024 Pages: 2347 - 2351
The first interim analysis of Italian patients enrolled in the real-world, Pan-European, prospective, observational, phase 4 PEARL study of fremanezumab effectiveness Cristina TassorelliPiero Barbantion behalf of the PEARL study group Clinical Trial article Open access 01 March 2024 Pages: 2353 - 2363
Marchiafava-Bignami disease: why not Marchiafava-Bignami-Carducci disease? Marianna BugianiOrso Bugiani History of Neurology 30 January 2024 Pages: 2365 - 2366
New insights on the potential effect of orexin receptor antagonist suvorexant on Parkinson’s disease symptoms Hayder M. Al-kuraishyAli I. Al-GareebGaber El-Saber Batiha Letter to the Editor Open access 17 January 2024 Pages: 2367 - 2368
Corpus callosum bilateral infarction in Sneddon disease Anna BolzanGiulia ToldoRoberto Bombardi Letter to the Editor 06 December 2023 Pages: 2369 - 2371
NICE lesions: an uncommon cause of stroke mimic following intracranial aneurysm embolization Adrien ter SchiphorstCaroline ArquizanCyril Dargazanli Letter to the Editor 08 December 2023 Pages: 2373 - 2376
Recurrent tumefactive demyelination under fingolimod treatment Merve İrişOsman KızılkılıçUğur Uygunoğlu Letter to the Editor 15 January 2024 Pages: 2377 - 2378
Causal associations between 25-hydroxyvitamin D levels and NMOSD: a two-Sample Mendelian randomization analysis Yunfei ZhuXiaoling ZhouQun Xue Letter to the Editor 04 January 2024 Pages: 2379 - 2381
Efficacy of lamotrigine in migralepsy: a case report Giacomo IabichellaMassimo AutunnoAngelo Labate Letter to the Editor 02 January 2024 Pages: 2383 - 2386
Very late onset methylmalonic acidemia (cblB type) as a cause of status epilepticus, leukoencephalopathy and myelopathy Michael BayatSándor BeniczkyJan Lykke Scheel Thomsen Letter to the Editor 22 December 2023 Pages: 2387 - 2391
Letter to the editor: Blurry vision as the initial symptom in Guillain-Barré syndrome: a case report Jin SongYan SongGuorong Zhang Letter to the Editor 11 January 2024 Pages: 2393 - 2394
Lemierre’s: a forgotten disease and a rare cause of cranial neuropathy – a case report Nikunj DavdaChristian BuckinghamGerard Davies Letter to the Editor 27 December 2023 Pages: 2395 - 2398
Amitriptyline induced rosacea-like rash Cristian FidanziGiorgia SalviaAgata Janowska Letter to the Editor 15 January 2024 Pages: 2399 - 2400
Recurrent lacunar strokes in a patient with small vessel disease: rare but not negligible cause of Foix-Chavany-Marie syndrome Maria Rosaria BagnatoIlaria CiulloMarina Diomedi Neuro-Images 01 February 2024 Pages: 2401 - 2402
Bilateral delayed non-ischemic enhancing brain lesions after treatment with flow-diverter Teresa PerilloAndrea Manto Neuro-Images 10 February 2024 Pages: 2403 - 2404
Correction to: Objective assessment of the effects of opicapone in Parkinson’s disease through kinematic analysis Matteo BolognaAndrea GuerraGiovanni Fabbrini Correction Open access 28 December 2023 Pages: 2405 - 2405
Correction to: Cognitive function in amyotrophic lateral sclerosis: a cross‑sectional and prospective pragmatic clinical study with review of the literature Adamantios KaterelosPanagiotis AlexopoulosElisabeth Chroni Correction Open access 19 February 2024 Pages: 2407 - 2407
